Apex Science & Engineering Corp.

Apex Science & Engineering Corp.

TTWSE:3052
10.35
TWD
-0.10
(-0.96%)
1.12EPS
9.57P/E
2.18BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
38.36
17.32
11.81
13.83
18.69
5.13
26.95
25.21
17.54
14.38
17.08
13.04
16.77
16.76
Basic EPS, GAAP
5.88
0.87
0.67
0.21
0.96
-0.65
0.84
1.53
0.5
1.01
1
0.98
1.1
1.12
Free Cash Flow per Basic Share
9.25
-1.02
-6.89
-2.41
2.81
-13.45
11.66
3.78
2.64
1.93
6.04
1.83
8.8
8.53
Dividend per Share
0.35
0.88
0.4
0.5
0.29
0.69
- -
0.49
0.78
0.24
0.39
0.4
0.51
- -
Book Value per Share
11.93
11.95
12.07
11.97
14.61
12.94
13.73
15.01
14.73
15.37
15.97
16.65
17.23
17.3
Tangible Book Value per Share
11.93
11.95
12.04
11.96
14.61
12.94
13.73
15.01
14.73
15.37
15.97
16.65
17.23
17.3
Basic Weighted Avg Shares
213
213
213
209
209
209
209
207
206
205
204
204
204
204
Sales/Revenue/Turnover
8,176
3,692
2,514
2,888
3,901
1,071
5,624
5,218
3,615
2,952
3,484
2,660
3,420
3,417
Operating Margin (%)
15.85
6.31
5.83
1.56
6.88
-19.09
4.26
5.53
1.88
7.07
6.36
7.17
7.71
5.54
Depreciation Expense
18
17
15
15
11
7
7
7
10
11
13
12
12
12
Net Income, GAAP
1,253
186
143
44
201
-136
175
316
103
207
205
200
224
228
Effective Tax Rate (%)
3.3
21.96
2.65
- -
10.43
- -
27.34
- -
23.82
24.36
24.18
20.04
18.96
1.31
Profit Margin (%)
15.32
5.03
5.68
1.54
5.15
-12.69
3.12
6.05
2.84
7.01
5.88
7.51
6.56
6.67
Working Capital
2,571
2,573
2,592
3,021
3,180
2,658
2,847
2,670
2,951
3,105
3,336
3,605
3,366
3,379
LT Debt
- -
- -
- -
494
495
496
498
31
510
498
547
531
12
8
Total Equity
3,066
3,028
3,046
2,974
3,116
2,830
2,983
3,141
3,084
3,223
3,347
3,487
3,603
3,620
Return on Invested Capital (%)
29.06
3.67
2.72
- -
3.87
- -
2.41
- -
0.9
2.59
2.6
2.09
2.97
2.7
Return on Capital (%)
29.56
4.32
3.46
- -
3.62
- -
2.74
- -
2.01
3.6
3.4
3.08
3.49
3.72
Return on Common Equity (%)
54.55
6.41
4.9
1.54
6.89
-4.78
6.3
10.66
3.4
6.75
6.41
6
6.49
6.56

Capital Structure

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
2,840
2,265
2,457
LT Borrowings
12
10
8
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
204
204
204
Market Capitalization
2,458
2,244
2,183

Working Capital

TWD

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
13,227
11,543
11,399
Cash, Cash Equivalents & STI
848
1,009
1,138
Accounts Receivable, Net
150
174
173
Inventories
1,121
1,157
1,174
Total Current Liabilities
9,861
8,128
8,020
Payables & Accruals
- -
- -
- -
ST Debt
2,840
2,265
2,457
Deferred Revenue
- -
- -
- -

Growth Rates

TWD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
1.8%
2.81%
3.33%
Free Cash Flow
-65.06%
92.83%
380.79%
Net Income, GAAP
0.85%
8.54%
12.25%
Sales/Revenue/Turnover
36.93%
-5.22%
28.59%
Total Cash Common Dividend
- -
15.22%
27.27%

Quarterly Revenue

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
698
747
578
637
2,660
2025
768
1,145
732
776
3,420
2026
871
1,039
- -
- -
- -

Quarterly Earnings Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.27
0.21
0.24
0.25
0.98
2025
0.34
0.32
0.29
0.15
1.1
2026
0.19
0.49
- -
- -
- -

Quarterly Dividends Per Share

TWD

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
- -
- -
0.4
2025
- -
- -
- -
- -
0.51
2026
- -
- -
- -
- -
- -

Company Description

CEO
Kuo Hua Kuo
Full Time Employees
208
Sector
Industrial services
Industry
Engineering & construction
Address
No.112, Shin-Min Street New Taipei NWT Taiwan 235
IPO Date
Nov 25, 1995
Business
Apex Science & Engineering Corp. (Ticker: 3052.TW) is a Taiwan-based company specializing in the development, manufacturing, and sale of laboratory instruments and scientific equipment. The company's core product portfolio includes chromatography instruments, mass spectrometers, analytical balances, and automation systems for scientific research and industrial applications. Apex also provides related services such as equipment installation, maintenance, and technical support. The company serves markets in Taiwan, Greater China, and international regions, targeting research institutions, pharmaceutical manufacturers, environmental analysis laboratories, and industrial users. Founded in 1998, Apex Science & Engineering Corp. is headquartered in Taoyuan City, Taiwan. In the last 1-2 years, Apex Science & Engineering Corp. has expanded its product offerings with new launches in advanced laboratory automation systems that enhance efficiency and precision in sample preparation and analysis. The company has also entered into strategic partnerships with global technology firms to integrate cutting-edge digital solutions into its product lines, improving connectivity and data management capabilities. Additionally, Apex has made operational improvements to its manufacturing processes to increase production capacity and reduce lead times, supporting its growth in international markets. No recent name changes or major reorganizations have been reported. These developments underscore Apex's commitment to innovation and market expansion within the scientific instrumentation industry.